Catalyst Wire Dossier Catalyst Wire Dossier

ARD-101

· Aardvark Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ARD-101, covering 2024-11-14 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial [Phase 3]

See pricing